0208080893 [email protected]
Providers / Bioss Primary Conjugated Antibodies. ALEXA FLUOR / HHV8 ORF50 Antibody, ALEXA FLUOR 594

Description:

Size: 100ul

Catalog no.: bs-0746R-A594

Price: 380 EUR

Get for 380 EUR on Gentaur.com

/ningbo-assets-bio/graphics/prods/bigs/bigs2.jpg

Product details

Modification Site

None

Virus

hhv8

Crossreactivity

Virus

Swiss Prot

O92608

Gene ID Number

4961526

Immunogen range

1-40/691

Tested applications

IF(IHC-P)

French translation

anticorps

Target Antigen

HHV8 ORF50

Modification

Unmodified

Clonality

Polyclonal

Concentration

1ug per 1ul

Excitation emission

590nm/617nm

Cross-reactive species details

HHV8 strain GK18

Conjugated with

ALEXA FLUOR® 594

Conjugated

Alexa conjugate 1

Recommended dilutions

IF(IHC-P)(1:50-200)

Clone

Polyclonal antibody

Purification

Purified by Protein A.

Conjugation

Alexa Fluor,ALEXA FLUOR® 594

Category

Conjugated Primary Antibodies

Host Organism

Rabbit (Oryctolagus cuniculus)

Also known as

Anti-HHV8 ORF50 PAb ALEXA FLUOR 594

Specificity

This is a highly specific antibody against HHV8 ORF50.

Long name

HHV8 ORF50 Polyclonal Antibody, ALEXA FLUOR 594 Conjugated

Source

KLH conjugated synthetic peptide derived from HHV8 ORF50 strain GK18

Synonyms

HHV 8; Human Herpes Virus 8; Human herpesvirus 8; HHV8 ORF50; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV; ORF50 protein.

Storage conditions

Store this antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Keep refrigerated at 2 to 8 degrees Celcius for up to one year.

Properties

For facs or microscopy Alexa 1 conjugate.If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies. ALEXA FLUOR they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Background of the antigen

HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.